Publications & Works

Publication Network
Articles 101
All (101)
SCI-E, SSCI, AHCI (59)
SCI-E, SSCI, AHCI, ESCI (73)
ESCI (12)
Scopus (77)
TRDizin (24)
Other Publications (19)

1. Safety of repeated trans-arterial radioembolization with multi-compartment dosimetry

SOYDAL Ç., Demir B., ARAZ M., Mesci I., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.
Annals of Nuclear Medicine , vol.39, no.12, pp.1306-1318, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy

KARAOĞLAN B. B., DURSUN E., Mesci İ., ARAZ M., KÖKSOY E. B.
Scientific Reports , vol.15, no.1, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Initial Multicenter Experience with [(161)Tb]Tb-PSMA in [(177)Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer: Preliminary Results.

Kucuk N. Ö., Coskun N., Araz M., Alan Selcuk N., Berberoglu K., Ozdemir E. C., et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine , 2025 (SCI-Expanded, Scopus) identifier

4. Prediction of [177Lu]Lu-PSMA-617 treatment response with [68Ga]Ga-PSMA-11 PET-derived variables and correlation of the overall survival with serum PSA and PSMA PET-based response criteria.

Ozkan E., Demir B., Soydal Ç., Araz M., Dursun E., Kucuk N. Ö., et al.
Revista espanola de medicina nuclear e imagen molecular , pp.500208, 2025 (Peer-Reviewed Journal) identifier

5. Integrated Dedicated Liver 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging of Hepatocellular Carcinoma and Correlations of Positron Emission Tomography with Diffusion-Weighted Imaging and Morphological Findings

Soydal Ç., Demir B., Kuru Oz D., Dursun E., Araz M., Kucuk N. Ö.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

6. 68Ga DOTATATE PET/MR Imaging of Well-Differentiated Primary and Metastatic Liver Neuroendocrine Tumors: Unified Evaluation and Correlations of PET, DCE, DWI, and T2-weighted Images

Soydal Ç., Demir B., Akkus Gunduz P., Baltacioglu M. H., Araz M., Kuru Oz D., et al.
CLINICAL NUCLEAR MEDICINE , vol.50, no.9, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

7. Hashimoto's encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment

İlhan R. S., Can K. C., Yalçın Şahiner Ş., Duman B., Çolak B., Kır Y., et al.
FRONTIERS IN PSYCHIATRY , vol.16, 2025 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

8. Suvmax of the lesion should be considered in the treatment plan for stage I non-small cell lung cancer

KOCAMAN G., Ibrahımov F., KAHYA Y., ARAZ M., ELHAN A. H., ENÖN S.
Annals of Nuclear Medicine , vol.39, no.8, pp.792-798, 2025 (SCI-Expanded, Scopus) identifier identifier

9. Retrospective chart review of cases of steroid-responsive catatonia: exploring a potential autoimmune aetiology

İlhan R. S., Rogers J. P., Can K. C., Duman B., Çolak B., Saka M. C., et al.
BJPSYCH OPEN , vol.11, no.5, 2025 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

10. Granulomatous Inflammation of Liver Mimicking Malignancy on 68Ga-FAPI PET/CT

ARAZ M., Dursun E., Mesci I., KONCA C., SOYDAL Ç., ÖZKAN E., et al.
CLINICAL NUCLEAR MEDICINE , vol.50, no.7, 2025 (SCI-Expanded) Sustainable Development identifier identifier identifier

11. Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival

SOYDAL Ç., ARAZ M., Demir B., ÖNEŞ T., SÖNMEZOĞLU K., Selcuk N. A., et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine , vol.66, no.7, pp.1097-1104, 2025 (SCI-Expanded, Scopus) identifier identifier

12. Diagnostic performance of fluorine-18-fluorodeoxyglucose PET/MRI for detection of disease recurrence in differentiated thyroid cancer: a compartment-based analysis

Özkan E., Ünal S., Akkuş P., Peker E., Araz M., Dursun E., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.46, no.3, pp.230-238, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

13. The prognostic role of pan-immune inflammation value in patients with metastatic castration resistance prostate cancer treated with Lutetium-177 (177Lu)-PSMA-617

YAZGAN S. C., Yekeduz E., ARAZ M., BÖLEK H., KÜÇÜK N. Ö., ÜRÜN Y.
Prostate , vol.85, no.1, pp.90-96, 2025 (SCI-Expanded, Scopus) identifier

14. Comparative evaluation of the performance of 18F-PSMA-1007 PET/CT and 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence Evaluación comparativa de los resultados de la PET/TC con [18F]F-PSMA-1007 y la PET/TC con [68Ga]Ga-PSMA-11 en los pacientes con recidiva bioquímica de cáncer de próstata

Inal G., SOYDAL Ç., Demir B., ARAZ M., ÜRÜN Y., BALTACI S., et al.
Revista Espanola de Medicina Nuclear e Imagen Molecular , 2025 (SCI-Expanded, Scopus) identifier

15. PET/MR in Breast Cancers

ARAZ M.
NUCLEAR MEDICINE SEMINARS , vol.10, 2024 (Peer-Reviewed Journal)

16. Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities.

Karaoğlan B. B., Öz D., Araz M., Akyol C., Utkan G.
Current oncology reports , vol.26, no.7, pp.791-803, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

17. Prognostic Importance of 18F-FDG Positron Emission Tomography in Uterine Cervical Cancer

Soydal Ç., Baltacıoğlu M. H., Araz M., Demir B., Dursun E., Taşkın S., et al.
Molecular Imaging and Radionuclide Therapy , vol.33, no.3, 2024 (ESCI)

18. Posterior cingulate cortex hyperactivity in conversion disorder: a PET/MRI study

TATLI S. Z., ARAZ M., ÖZKAN E., PEKER E., Erden M., ŞENTÜRK CANKORUR V.
Frontiers in Psychiatry , vol.15, 2024 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier identifier

19. Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

Soydal Ç., Demir B., Sütçü G., Araz M., Küçük N. Ö.
Molecular imaging and radionuclide therapy , vol.32, no.2, pp.150-152, 2023 (ESCI, TRDizin) Creative Commons License identifier identifier identifier identifier

20. Long-term effects of radioiodine treatment on thyroid functions and ultrasonographic features in patients with toxic adenoma and toxic multinodular goitre

Koç I., Bahçecioğlu A. B., AVCI MERDİN F., ARAZ M., ERDOĞAN M. F.
Annals of Nuclear Medicine , vol.37, no.6, pp.371-379, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

21. The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions

ARAZ M., SOYDAL Ç., SÜTÇÜ G., Kivrak H., Sak S., KIR K. M., et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.280, no.6, pp.2905-2910, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

22. The Role of (18)F-FDOPA PET/CT in Recurrent Medullary Thyroid Cancer Patients with Elevated Serum Calcitonin Levels.

Araz M., Soydal Ç., Demir Ö., Gökcan M. K., Küçük N. Ö.
Molecular imaging and radionuclide therapy , vol.32, no.1, pp.1-7, 2023 (ESCI, TRDizin) identifier identifier identifier

23. Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study

Akkus Gunduz P., ÖZKAN E., KURU ÖZ D., SOYDAL Ç., ARAZ M., ERDEN G. A., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.44, no.2, pp.150-160, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

24. Can Serum Thyroglobulin Levels Help to Identify the Involved Neck Compartment of Differentiated Thyroid Carcinoma?

Bahcecioglu A. B., Ozkan E., Araz M., Elhan A. H., Erdogan M. F.
HORMONE AND METABOLIC RESEARCH , vol.54, no.10, pp.658-663, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

25. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer

KUBİLAY E., Akpinar Ç., OĞUZ E. S., ARAZ M., SOYDAL Ç., BALTACI S., et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.40, no.9, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

26. A Rare Pitfall in Bone Mineral Densitometry Gaucher Disease

ARAZ M., SÜTÇÜ G., Surucu Kara L., Eminoglu T., ÖZKAN E.
CLINICAL NUCLEAR MEDICINE , vol.47, no.8, 2022 (SCI-Expanded) identifier identifier identifier

27. Liver Blood Pool Imaging and Selective Spleen Scintigraphy

ARAZ M.
NUCLEAR MEDICINE SEMINARS , vol.8, 2022 (Peer-Reviewed Journal)

28. Elevated Angiogenic Factor Levels After Transarterial Radioembolization for Colorectal Cancer Liver Metastases May Predict a Poor Prognosis

Soydal Ç., Araz M., Durmaz M., Özkan E., Ergüder B. İ., Küçük N. Ö., et al.
Molecular Imaging and Radionuclide Therapy , vol.31, no.2, pp.114-122, 2022 (Scopus, TRDizin) Sustainable Development identifier identifier identifier identifier

29. Detectability of 18F-choline PET/MR in primary hyperparathyroidism

Araz M., Nak D., Soydal Ç., Peker E., Erden İ., Küçük N. Ö.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.279, no.5, pp.2583-2589, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

30. Aumento difuso de la captación en los conductos biliares intrahepáticos en18F-FDG-PET/TC en un caso de colangitis esclerosante primaria

Araz M., Gündüz P., Baltacıoğlu M. H., Soydal Ç., Kır K. M.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.41, pp.4-5, 2022 (SCI-Expanded, Scopus)

31. Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer

Araz M., Soydal Ç., Özkan E., Sen E., Nak D., Kucuk O. N., et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.66, no.1, pp.61-66, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

32. Correlation of cancer status and brown adipose tissue activity on 18F-flourodeoxyglucose positron emission tomography/computed tomography

ARAZ M., GÜLPINAR B., GÜNDÜZ P., ÖZKAN E., ŞAHİN M.
Turkish Journal of Clinics and Laboratory , vol.13, pp.52-58, 2022 (TRDizin) Sustainable Development identifier

33. Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma

Araz M., Özkan E., Gündüz P., Soydal Ç., Küçük N. Ö., Kır K. M.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, pp.56-62, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

34. Myocardial perfusion SPECT findings in postCOVID period

Araz M., Soydal Ç., Sütçü G., Demir B., Özkan E.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.3, pp.889-894, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

35. Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.1, pp.49-56, 2022 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

36. Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma

SOYDAL Ç., VARLI B., ARAZ M., BAKIRARAR B., TAŞKIN S., ORTAÇ U. F.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, pp.762-769, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

37. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer

Soydal Ç., Araz M., Ürün Y., Nak D., Özkan E., Küçük N. Ö.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.65, no.3, pp.282-286, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

38. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters

Araz M., Soydal Ç., Özkan E., Akkus P., Nak D., Küçük N. Ö., et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.36, no.5, pp.425-432, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

39. Gallbladder Uptake Mimicking Liver Metastasis on Lu-177-DOTATATE Posttherapy Scan Gallbladder Uptake on Lu-177-DOTATATE Scan

Araz M., Baltacıoğlu M. H., Saglam S., Ozguven M. A., Küçük N. Ö.
CLINICAL NUCLEAR MEDICINE , vol.46, no.3, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

40. A Rare Extramedullary Presentation of Multiple Myeloma: Paraspinal Muscle Involvement Revealed by FDG PET/CT

Özkan E., Araz M., Cengiz Seval G., Nak D., Beksaç M.
TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.1, pp.69-71, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

41. Should the Place of Radioactive Iodine Whole Body Scintigraphy in Follow-up of Differentiated Thyroid Cancer Reevaluated in the Era of SPECT/CT?

Araz M., Küçük N. Ö.
Nuclear Medicine Seminars , vol.7, 2021 (Peer-Reviewed Journal) Creative Commons License Sustainable Development

42. The Role of Nuclear Medicine in the Diagnosis of NETs

Özkan E., Araz M.
Nuclear Medicine Seminars , vol.7, 2021 (Peer-Reviewed Journal) Creative Commons License

43. Ga-68 DOTATATE PET/CT in the Evaluation of Therapy Response in Neuroendocrine Tumors

Küçük N. Ö., Araz M.
Nuclear Medicine Seminars , vol.7, 2021 (Peer-Reviewed Journal) Creative Commons License

44. Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers

Özkan E., Araz M.
Nuclear Medicine Seminars , vol.7, 2021 (Peer-Reviewed Journal) Creative Commons License Sustainable Development

45. Intense F-18-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

Soydal Ç., Gündüz P., Araz M., Utkan G.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.29, no.2, pp.79-81, 2020 (ESCI, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier

46. Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

SOYDAL Ç., AKKUŞ P., ARAZ M., UTKAN G.
Molecular Imaging and Radionuclide Therapy , vol.29, no.2, pp.79-81, 2020 (ESCI, Scopus, TRDizin)

47. Incidental F-18-Fluorocholine Uptake in an Esophageal Diverticulum F-18-FCH in an Esophageal Diverticulum

Araz M., Cinel M., Soydal Ç., Özkan E., Küçük N. Ö.
CLINICAL NUCLEAR MEDICINE , vol.45, no.4, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

48. Radionuclide Methods for Pain Palliation

Araz M., Akkuş P.
Nuclear Medicine Seminars , vol.6, no.1, pp.20-27, 2020 (Peer-Reviewed Journal) Creative Commons License

49. Developments in Pain Imaging

Soydal Ç., Araz M.
Nuclear Medicine Seminars , vol.6, no.1, pp.1-4, 2020 (Peer-Reviewed Journal) Creative Commons License

50. Four Atypical Parathyroid Adenomas Detected by Dual Phase Tc-99m MIBI SPECT

Araz M., Cayir D., Koybasioglu F. F., Karabacak H., Cakal E.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.29, no.1, pp.33-36, 2020 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

51. An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT

Araz M., Soydal Ç., Ozturk C., Özkan E., Demirer T.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.47, no.1, pp.218-219, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

52. Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma

Soydal Ç., Araz M., Nak D., Akku P., Baltacıoğlu M. H., Bilgic S., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.1, pp.73-77, 2020 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

53. First Experience of C-11-Methionine PET in Multiple Myeloma in Turkey

Ozkan E., Cengiz Seval G., Araz M., Kucuk N. Ö., Beksaç M.
TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.1, pp.66-67, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

54. Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings

Gülpınar B., Peker E., Soydal Ç., Araz M., Elhan A. H.
BRITISH JOURNAL OF RADIOLOGY , vol.93, no.1106, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

55. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma

Soydal Ç., Nak D., Araz M., Akkus P., Ürün Y., Özkan E., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.40, no.12, pp.1243-1249, 2019 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

56. F-18-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value

Soydal Ç., Araz M., Ürün Y., Gülpınar B., Nak D., Özkan E., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.40, no.12, pp.1268-1274, 2019 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier

57. Ga-68-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor

Soydal Ç., Nak D., Araz M., Demirkazık A., Küçük N. Ö.
CLINICAL NUCLEAR MEDICINE , vol.44, no.10, pp.795-796, 2019 (SCI-Expanded, Scopus) Creative Commons License identifier

58. Intense Pituitary 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake in a Patient with Diabetes Insipidus

Soydal Ç., Nak D., Araz M., Taçyıldız N., Küçük N. Ö.
BALKAN MEDICAL JOURNAL , vol.36, no.4, pp.253-254, 2019 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

59. Nuclear Medicine Applications in Diagnosis of Urological Tumors

Araz M., Ürün Y.
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.18, no.2, pp.80-88, 2019 (ESCI) Creative Commons License Sustainable Development identifier

60. The efficacy of fluorine-18-choline PET/CT in comparison with Tc-99m-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism

Araz M., Soydal Ç., Özkan E., Kır K. M., İbiş E., Güllü S., et al.
NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11, pp.989-994, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

61. Clinical Significance of Incidental Pituitary TC-99m MIBI Uptake on Parathyroid Spect and Factors Affecting Uptake Intensity

Araz M., Cayir D., Ucan B., Dilli A., Cakal E.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.33, no.7, pp.295-299, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

62. The relationship between semiquantitative parameters derived from technetium-99m metoxyisobutylisonitrile dual-phase parathyroid single-photon emission computed tomography images and disease severity in primary hyperparathyroidism

Cayir D., ARAZ M., Yalcindag A., Cakal E.
NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.4, pp.304-311, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

63. Inguinal Endometriosis Visualized on I-131 Whole Body Scan

Cayir D., ARAZ M., Apaydin M., Cakal E.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.27, no.1, pp.52-54, 2018 (ESCI, Scopus, TRDizin) identifier

64. Karaciğer tümörlerinde intraarteriyel mikroküre tedavisi sonuçları

ARAZ M., KÜÇÜK N. Ö.
Türkiye Klinikleri , pp.26-31, 2018 (TRDizin)

65. Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule

Cayir D., ARAZ M., Akin S., Karakose M., Cakal E.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.26, no.3, pp.128-130, 2017 (ESCI, Scopus, TRDizin) Sustainable Development identifier identifier

66. Cyclosporine and Vancomycin

Cayir D., ARAZ M., Filik M., Erdogan M.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.26, no.3, pp.124-127, 2017 (ESCI) identifier identifier

67. Bifid Pelvis Appearance and Yo-Yo Reflux on Dynamic Renal Scintigraphy: Two Case Reports

ARAZ M., ÇAYIR D.
International Journal of Nuclear Medicine Research , vol.4, no.1, pp.15-18, 2017 (Peer-Reviewed Journal)

68. Evaluation of Residual Thyroid Tissue with Tc-99m MIBI in Differential Thyroid Carcinoma Patients: A Case Report

ÇAYIR D., ARAZ M., UÇAN B., ÇAKAL E.
International Journal of Nuclear Medicine Research , vol.4, no.1, pp.13-14, 2017 (Peer-Reviewed Journal)

69. Radioiodine Therapy of Benign Thyroid Diseases

ÇAYIR D., ARAZ M.
International Journal of Nuclear Medicine Research , vol.4, no.1, pp.6-12, 2017 (Peer-Reviewed Journal)

70. Factors affecting the sensitivity of Tc-99m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism

ARAZ M., Cayir D., Erdogan M., Ucan B., Cakal E.
NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.2, pp.117-123, 2017 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

71. F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Other Thyroid Cancers: Medullary, Anaplastic, Lymphoma and So Forth

ARAZ M., Cayir D.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.26, no.1, pp.1-8, 2017 (ESCI, Scopus, TRDizin) Sustainable Development identifier identifier

72. Comparison of 18F-FDG PET/CT and ceCT results in the assessment of RCC recurrence

ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.
Studies on Stem Cells Research and Thearpy , vol.3, no.1, pp.1-5, 2017 (Peer-Reviewed Journal)

73. May preablative thyroglobulin level be a prognostic indicator for papillary thyroid cancer?

ÖZKAN E., SOYDAL Ç., ARAZ M., GENÇ Y., KÜÇÜK N. Ö.
Clinical and Medical Investigations , vol.2, no.1, pp.1-16, 2017 (Peer-Reviewed Journal) Creative Commons License Sustainable Development

74. Scintigraphic Appearance of an Incidental Giant Hydronephrosis in a Pediatric Patient

Cayir D., ARAZ M.
Journal of Nephrology and Urology Research , vol.4, no.1, pp.1-2, 2016 (Peer-Reviewed Journal)

75. Giant Urinary Bladder Visualised on Tc-99m MDP Whole Body Bone Scan

Cayir D., ARAZ M., GÜLTEKİN S. S.
Journal of Nephrology and Urology Research , vol.4, no.1, pp.3-4, 2016 (Peer-Reviewed Journal)

76. Unexpected Appearance of Ectopic Mediastinal Toxic Nodulary Thyroid Hyperplasia in a Case of Recurrent Hyperthyroidism

ARAZ M., ÇAYIR D., ÇOLAK BOZKURT N., YAZICI Ü., ÇAKAL E.
International Journal of Nuclear Medicine Research , vol.3, no.2, 2016 (Peer-Reviewed Journal)

77. Scintigraphic evaluation of renal functional damage in volatile substance abusers

Cayir D., Demirel K., Korkmaz M., ARAZ M., Koca G.
NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.6, pp.623-631, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

78. Association between mean platelet volume and bone mineral density in postmenopausal women

AYPAK C., Türedi Ö., Bircan M. A., Civelek G. M., ARAZ M.
Journal Of Physical Therapy Science , vol.28, no.6, pp.1753-1758, 2016 (Scopus) Sustainable Development identifier identifier

79. Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
International Journal of Nuclear Medicine Research , vol.3, 2016 (Peer-Reviewed Journal)

80. Association of haematological parameters with bone mineral density in elderly diabetic women

Aypak C., Turedi O., Bircan M. A., ARAZ M.
ACTA CLINICA BELGICA , vol.70, no.5, pp.339-344, 2015 (SCI-Expanded, Scopus) Sustainable Development identifier

81. The role of 18F-NaF PET/CT in metastatic bone disease

ARAZ M., Aras G., KÜÇÜK N. Ö.
JOURNAL OF BONE ONCOLOGY , vol.4, no.3, pp.92-97, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

82. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment

SOYDAL Ç., ARAZ M., ÖZKAN E., Arslantas E., KÜÇÜK N. Ö., Aras G.
NUCLEAR MEDICINE COMMUNICATIONS , vol.36, no.2, pp.109-113, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

83. Different Uptake Patterns of Tc-99m MDP on Three Phase Bone Scan in a Neurofibromatosis Type I Patient with Multiple Neurofibromas and Neurofibrosarcoma: Case Report

ÖRS Ç. D., ARAZ M., BAKIRHAN Ü., ERDOĞAN M., DİLLİ A.
Türkiye Klinikleri Tip Bilimleri Dergisi , vol.35, no.4, pp.279-283, 2015 (Scopus) identifier

84. Bilobar Thyroid Pyramidal Lobe: Original Image

ÖRS Ç. D., ARAZ M.
Türkiye Klinikleri Tip Bilimleri Dergisi , vol.35, no.4, pp.287-288, 2015 (Scopus)

85. Use of Osteoporosis Medications Among Turkish Patients

Aypak C., Turedi O., Bircan M. A., ARAZ M., Yikilkan H., Akbiyik D. I., et al.
JOURNAL OF CLINICAL PHARMACOLOGY , vol.54, no.11, pp.1318-1319, 2014 (SCI-Expanded) identifier identifier identifier

86. Prognostic Importance of F-18-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., Bilgic S., İBİŞ E.
CLINICAL NUCLEAR MEDICINE , vol.38, no.7, 2013 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

87. Evaluation of the Response to Selective Internal Radiation Therapy in Patients With Hepatocellular Cancer According to Pretreatment Tc-99m-MAA Uptake

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., Aras G.
CLINICAL NUCLEAR MEDICINE , vol.38, no.4, pp.252-255, 2013 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

88. Intense Ga-68 Dotatate Uptake in Recurrent MTC Patient

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.
World Journal of Endocrine Surgery , vol.4, no.3, pp.118-119, 2012 (Scopus) Creative Commons License identifier

89. Unexpected F-18-FDG uptake in an ocular prosthesis

ÖZKAN E., ARAZ M., SOYDAL Ç., Aras G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.39, no.9, pp.1517-1518, 2012 (SCI-Expanded) identifier

90. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G.
NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.9, pp.990-994, 2012 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

91. The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.
CLINICAL NUCLEAR MEDICINE , vol.37, no.8, pp.755-758, 2012 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

92. Detection of Intraluminal Tracheal Metastasis of Thyroid Papillary Carcinoma by F-18-FDG PET/CT

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö., İBİŞ E.
CLINICAL NUCLEAR MEDICINE , vol.37, no.6, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

93. The role of F-18-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels

ÖZKAN E., SOYDAL Ç., ARAZ M., KIR K. M., İBİŞ E.
NUCLEAR MEDICINE COMMUNICATIONS , vol.33, no.4, pp.395-402, 2012 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

94. Clinical Experience of F-18-FDG PET/CT in Soft Tissue and Osseous Sarcomas

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.3, pp.163-169, 2012 (SCI-Expanded, Scopus, TRDizin) identifier identifier

95. The role of intraoperative gamma probe and parathyroid hormone measurement in the localization of intrathyroidal parathyroid adenoma

SOYDAL Ç., GENÇ V., ARAZ M., AKYOL C., KÜÇÜK N. Ö.
World Journal of Endocrine Surgery , vol.4, no.2, pp.77-78, 2012 (Scopus) Creative Commons License identifier

96. Differentiated thyroid carcinomas in childhood: clinicopathologic results of 26 patients

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.24, no.9-10, pp.739-742, 2011 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

97. The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer: Comparison with spiral CT

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.
WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.9, 2011 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

98. Nuclear medicine applications in pediatric oncology: Review Pediatrik onkolojide nükleer tip uygulamalari

ARAZ M., KÜÇÜK N. Ö.
Turkiye Klinikleri Pediatri , vol.20, no.2, pp.151-168, 2011 (Scopus) Sustainable Development identifier

99. Ocular involvement in mantle cell lymphoma detected by F 18 FDG PET CT

Özkan E., Laçin S., Soydal Ç., Araz M., Küçük N. Ö.
Molecular Imaging and Radionuclide Therapy , vol.20, no.1, pp.36-37, 2011 (TRDizin) identifier identifier

100. Pediatrik onkolojide nükleer tıp uygulamaları

ARAZ M., KÜÇÜK N. Ö.
Türkiye Klinikleri Journal of Pediatr , vol.20, no.2, pp.151-168, 2011 (Peer-Reviewed Journal) identifier

101. Differentiated thyroid corcinomas in childhood: clinicopathologic results of 26 patients

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö.
Journal of Pediatric Endocrinology and Metabolism , vol.24, no.9-10, pp.739-742, 2011 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 123

1. Correlation Between PRIMARY Scores in Ga-68 PSMA PET and Histological ISUP Grades in Prostate Cancer

SOYDAL Ç., ÇİDEMAL M., ARAZ M., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

2. Interim Analysis of Effect of Hypoxia on F-18 MISO PET to Response to Lu-177 PSMA Treatment (LuMISO)Trial

SOYDAL Ç., DURSUN E., DEMİR B., SÜTÇÜ G., ARAZ M., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

3. Variations in F-18-FMISO Physiological Uptake

ARAZ M., MESCİ İ., DURSUN E., SOYDAL Ç., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

4. Quantitative Tc-99m MIBI SPECT/CT parameters can predict malignancy in indeterminate thyroid nodulespreliminary results

ARAZ M., MESCİ İ., DURSUN E., SOYDAL Ç., AKSU O., ERASLAN E., et al.
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 October 2025, (Full Text)

5. F-18 FES PET’in Metastatik Meme Kanserinde Östrojen Reseptör Heterojenitesinin Gösterilmesindeki Yeri

DURSUN E., ÖZKAN E., SOYDAL Ç., KÜÇÜK N. Ö., ARAZ M., DEMİR B., et al.
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

6. Çok Kompartmanlı Dozimetri ile Tekrarlayan Transarteriyel Radyoembolizasyonun Güvenilirliği

SOYDAL Ç., DEMİR B., ARAZ M., ÇELEBİOĞLU E. C., KÜÇÜK N. Ö.
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

7. Pankreasta ve Uterusta Fizyolojik Ga-68 FAPİ Tutulumu

MESİCİ İ., SOYDAL Ç., DURSUN E., ARAZ M., KÜÇÜK N. Ö.
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 April 2025, (Full Text)

8. Osteoporoz ve periodontitis tedavisinin sistemik-mandibular kemik mineral yoğunluğu, yaşam kalitesine (QUALEFFO-41) etkisi / Osteoporosis and periodontitis treatment impact on bone density and quality of life

KARAASLAN R., FENTOĞLU Ö., GÖKÇAY CANPOLAT A., BAĞIŞ N., ARAZ M., BAŞ AKSU Ö.
Türk Periodontoloji Derneği 53. Bilimsel Kongresini ve 31. Bilimsel Sempozyumu, Turkey, 07 November 2024, (Full Text)

9. Osteoporoz ve Periodontitis Tedavisinin Sistemik-Mandibular Kemik Mineral Yoğunluğu Ve Yaşam Kalitesine (QUALEFFO-41) Etkisi.

KARAASLAN R., BAŞ AKSU Ö., ARAZ M., GÖKÇAY CANPOLAT A., BAĞIŞ N., ORHAN H., et al.
Türk Periodontoloji Derneği 53. Uluslararası Bilimsel Kongresi, Turkey, 14 November 2024, (Full Text)

10. Lutesyum-177 (177Lu)-PSMA-617 ile tedavi edilen metastatik kastrasyon dirençli prostat kanseri hastalarında Pan-İmmün inflamasyon değerinin prognostik Rolü

YAZGAN S. C., YEKEDÜZ E., ARAZ M., BÖLEK H., KÜÇÜK N. Ö., ÜRÜN Y.
On TARGED Master Oncology, 26 - 29 October 2024, (Full Text)

11. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

ARAZ M., SOYDAL Ç., DURSUN E., MESCİ İ., KONCA C., ÖZKAN E., et al.
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.17, (Full Text)

12. Dual FES/FDG PET/CT imaging to predict therapy response in patients with estrogen receptor-positive recurrent or metastatic breast cancer: Preliminary Results

DURSUN E., ÖZKAN E., YAŞAR H. A., ARAZ M., AKSOY S., ÜRÜN Y., et al.
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.493-494, (Full Text)

13. F18-FCH uptake in thyroid parenchymal diseases

ARAZ M., SOYDAL Ç., DEMİR B., SÜTÇÜ G., GÖKÇAY CANPOLAT A., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.367-368, (Full Text)

14. Transarterial radioembolization (TARE) in Colorectal metastasis of liver (TACOME) trial

SOYDAL Ç., ARAZ M., DEMİR B., ÖNEŞ T., SÖNMEZOĞLU K., ALAN SELÇUK N., et al.
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 October 2024, vol.51, pp.407-408, (Full Text)

15. Comparison of Ga-68 FAPI PET/CT and F18-FDG PET/CT in primary staging of breast cancer

ARAZ M., SOYDAL Ç., DURSUN E., Mesci İ., KONCA C., ÖZKAN E., et al.
Annual Congress of the European Association of Nuclear Medicine October 19–23, 2024 Hamburg, Germany, Hamburg, Germany, 19 October 2024, vol.51, pp.17, (Summary Text) identifier identifier

16. Diverse etiologies and targeted therapeutic approaches in catatonia: a retrospective cohort study

İlhan R. S., Çolak B., Can K. C., Erdoğan S., Yılmaz R., Araz M., et al.
37th ECNP Congres, Milan, Italy, 21 - 24 September 2024, (Full Text)

17. Case report: levetiracetam-induced catatonia

Emri C., Özçelik K., İLHAN R. S., ERDOĞAN S., DUMAN B., ÇOLAK B., et al.
37th ECNP Congress, Milan, Italy, 21 September 2024, (Summary Text)

18. Lu-177 PSMA tedavisine yanıtın RECIP kriterleri ve PSA düzeyi ile değerlendirilmesi ve sağkalım ile korelasyonu

ÖZKAN E., DEMİR B., SOYDAL Ç., DURSUN E., ARAZ M., ÜRÜN Y., et al.
36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)

19. Biyokimyasal nüks izlenen prostat Ca hastalarında F-18 PSMA PET/BT'nin başarısının değerlendirilmesi.

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.
36.Ulusal Nükleer Tıp Kongresi, 8 - 12 May 2024, (Full Text)

20. Hybrıd F18-FDG PET/MRI in endometrial cancer: staging accuracy, quantitative analysis, and imaging characteristics of histological subtypes

KURU ÖZ D., ARAZ M., Yılmazer Zorlu N. S., VARLI B., SOYDAL Ç., TAŞKIN S., et al.
European Congress of Radiology, ECR 2024, Austria, 28 February - 03 March 2024, (Full Text)

21. Steroid-Responsive catatonia associated with possible autoimmune enchephalitis - A Case Series

İlhan R. S., Duman B., Can K. C., Çolak B., Yılmaz R., Erdoğan S., et al.
36th ECNP Congress, Barcelona, Spain, 7 - 10 October 2023, (Full Text)

22. Intravenous immunoglobulin responsive postinfectious Covid-19 Catatonia - A case report

Keser E., Kılıç U., İlhan R. S., Can K. C., Saydan B., Duman B., et al.
36Th ECNP Congress, Barcelona, Spain, 7 - 10 October 2023, (Full Text)

23. Comparison of C-11 methionine and F-18 FDG PET/CT findings in evaluation of multiple myeloma: first Turkey Experience

ÖZKAN E., DEMİR B., CENGİZ SEVAL G., ARAZ M., SOYDAL Ç., BEKSAÇ M., et al.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

24. Does peritoneal metastasis evaluation with 18F-FDG PET/MRI contribute to prognosis prediction in patients with ovarian cancer

BALTACIOĞLU M. H., SOYDAL Ç., ARAZ M., KURU ÖZ D., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

25. PRe-treatment 68Ga-PSMA PET/CT parameters could predict response to 177Lu-PSMA tretament and overall survival in metastatic castration resistant prostate carcinoma patients treated with 177Lu-PSMA

ÖZKAN E., DEMİR B., ÖZTÜRK M., ARAZ M., SOYDAL Ç., DURSUN B., et al.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

26. Comparison of 18F-FDG PET/CT and 18F-FDG PET/MRI in detection of liver lesions in hepatocellular carcinoma for staging and restaging

DEMİR B., SOYDAL Ç., DURSUN E., ARAZ M., KURU ÖZ D., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

27. Evaluaion of the success of 18F-PSMA PET/CT in the detection odf prostate cencer recurrence in patients with biochemical recurrence

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

28. Prognostic value of F-18 FDG PET/CT metabolic parameters in prostate cancer patients

SOYDAL Ç., BALTACIOĞLU M. H., ARAZ M., DEMİR B., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

29. Comparison of 68Ga-DOTATATE PET/CT and 68Ga-DOTATATE PET/MR in detection of neuroendocrine tumour liver metastasis

DEMİR B., SOYDAL Ç., ARAZ M., BALTACIOĞLU M. H., KURU ÖZ D., KÜÇÜK N. Ö.
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 September 2023, (Full Text)

30. Long-Term efeects of radioiodine treatment on thyroid functions, thyroid volume, nodüle volume and ultrasonografphic features in patients with toxic adenoma and toxic multinodüler goitre

KOÇ I., BAHÇECİOĞLU MUTLU A. B., AVCI MERDİN F., ARAZ M., ERDOĞAN M. F.
25th European Congress of Endocrinology, 13 - 16 May 2023, (Full Text)

31. Multiple myelomada hastaık değerlendirilmesinde C-11 Metiyonin PET/BT deneyimi

ÖZKAN E., DEMİR B., CENGİZ SEVAL G., ARAZ M., SOYDAL Ç., BEKSAÇ M., et al.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)

32. Multiple myelomada hastalık değerlendirilmesinde C-11 Metiyonin PET/BT deneyimi

ÖZKAN E., DEMİR B., CENGİZ SEVAL G., ARAZ M., SOYDAL Ç., BEKSAÇ M., et al.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)

33. Hepatoselüler kanserli hastalarda 18F-FDG PET/MR'nin 18F-FDG PET/BT karşılaştırılması

SOYDAL Ç., DEMİR B., DURSUN E., ARAZ M., KURU ÖZ D., KÜÇÜK N. Ö.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)

34. Nöroendokrin tümör karaciğer metastazlarında 68Ga DOTATATE PET/BT ve PET/MR'in karşılaştırılması

SOYDAL Ç., DEMİR B., ARAZ M., BALTACIOĞLU M. H., KURU ÖZ D., KÜÇÜK N. Ö.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)

35. Prostat kanserli hastalarda 18F/FDG PET/BT metabolik parametrelerinin prognostik önemi

SOYDAL Ç., BALTACIOĞLU M. H., ARAZ M., DEMİR B., KÜÇÜK N. Ö.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)

36. PET/MR ile yapılan peritoneal metastaz değerlendirmesi over kanserli hastalarda prognoz tahminine ek katkı sağlıyor mu?

Baltacıoğlu M. H., Soydal Ç., Araz M., Kuru Öz D., Küçük N. Ö.
35.Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 26 April 2023, (Full Text)

37. Uterin serviks kanserli hastalarda 18F-FDG PET'in prognostik yeri: 10 yıllık deneyim.

SOYDAL Ç., BALTACIOĞLU M. H., ARAZ M., TAŞKIN S., KÜÇÜK N. Ö., ORTAÇ U. F.
35.Ulusal Nükleer Tıp Kongresi, 26 April 2023, (Full Text)

38. Endometrium kanserinde hibrid F-18-DG PET/MRG: evreleme başarısı, kantitatif değerlendirme, histolojik alt tiplerin görüntüleme özellikleri

KURU ÖZ D., ARAZ M., VARLI B., SOYDAL Ç., YAVUZ Z., TAŞKIN S., et al.
43.Ulusal Radyoloji Kongresi, 2022, 01 November 2022, (Summary Text)

39. The Relationship between 18F-FCH uptake intensity and Cell Content in Parathyroid Lesions

ARAZ M., SOYDAL Ç., KIVRAK H., SAK S., SÜTÇÜ G., KIR K. M., et al.
35th Annual Congress of the European Association of Nuclear Medicine, Barselona, Spain, 15 October 2022, vol.49, pp.136, (Summary Text)

40. Head-to-head comparison of 18F-FDG PET/CT and PET/ MRI for the imaging of peritoneal recurrence of ovarian carcinoma

BALTACIOĞLU M. H., SOYDAL Ç., ARAZ M., KURU ÖZ D., TAŞKIN S., KÜÇÜK N. Ö., et al.
Annuals Congress of the European Association of Nuclear Medicine, 15 October 2022, (Summary Text)

41. RAI tedavisi sonrası I-131 tüm vücut taramada protez gözde radyoaktif iyot tutulumu.

ARAZ M., BALTACIOĞLU M. H., DURSUN E., DEMİR B., SOYDAL Ç., ÖZKAN E., et al.
34.Ulusal Nükleer Tıp Kongresi, Turkey, 27 March - 31 August 2022, (Full Text)

42. Evaluation of brain functions in conersion disordr with PET/MRI

TATLI S. Z., ÖZKAN E., ARAZ M., ERDEN M. İ., ŞENTÜRK CANKORUR V.
Abstracts of the 30th European Congress of Psychiatry, 04 June 2022, (Full Text)

43. F-18 FCH PET/BT ile Saptanan Tc-99m MIBI Negatif İntratimik Paratiroid Adenomu

ARAZ M., GÖRGÜNER F., KEPENEKCİ BAYRAM İ., KAYI CANGIR A., ÖZKAN E., KÜÇÜK N. Ö.
34.Ulusal Nükleer Tıp Kongresi, 27 March 2022, vol.8, pp.102, (Summary Text)

44. DBBHL’Lİ Olguda Nadir Ekstranodal Tutulumlar

ARAZ M., GÜNDÜZ P., BALTACIOĞLU M. H., SÜTÇÜ G., ÖZKAVUKCU E., YÜKSEL M., et al.
34.Ulusal Nükleer Tıp Kongresi, 27 March 2022, vol.8, pp.157-158, (Summary Text)

45. Kardiyak Metastaz Saptanan Dil Kanseri Olgusunda F-18 FDG PET/BT ve MPS Bulguları

ARAZ M., BALTACIOĞLU M. H., GÜNDÜZ P., SOYDAL Ç., ÖZKAN E., KÜÇÜK N. Ö.
34.Ulusal Nükleer Tıp Kongresi, 27 March 2022, vol.8, pp.137-138, (Summary Text)

46. Added value of F18-FDG PET/MR imaging for detecting liver metastases in patients with colorectal cancer

GÜNDÜZ P., ÖZKAN E., KURU ÖZ D., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö., et al.
Annuals Congress of the European Association of Nuclear Medicine, 20 October 2021, vol.48, pp.184, (Full Text) Sustainable Development

47. Myocardial perfusion SPECT findings in postcovid period

ARAZ M., SÜTÇÜ G., DEMİR B., ÖZKAN E., SOYDAL Ç.
Annuals Congress of the European Association of Nuclear Medicine, 2021, 20 October 2021, vol.48, pp.184, (Full Text)

48. Radiomics analyses in 18F-FDG PET images of breast carcinoma to predict hormone receptor statut: histopathological correlational study

ARAZ M., SOYDAL Ç., GÜNDÜZ P., KIRMIZI B. A., BAKIRARAR B., SAK S., et al.
SNMMI 2021 Virtual Annual Meeting, 11 June 2021, (Full Text)

49. Radiomics analysis o uterine tumors in 18F-flourodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma

SOYDAL Ç., VARLI B., ARAZ M., TAŞKIN S., BAKIRARAR B., ORTAÇ U. F.
SNMMI 2021 Virtual Annual Meeting, 11 June 2021, (Full Text)

50. Bilateral adrenal masses caused by extramedullary hematopoiesis detected by 18F-FLT PET/CT

KORKMAZ F. N., DEMİR Ö., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., CEYHAN K., et al.
23rd Eupopean Congress of Endocrinology 2021, 22 May 2021, vol.73, (Full Text)

51. Postinduction FDG-PET imaging improves the impact of biochemical response assessment on transplant outcome.

Cengiz Seval G., Özkan E., Araz M., Kırcalı E., Koyun D., Gürman G., et al.
8th International Congress on Leukemia Lymphoma Myeloma, 2021, İstanbul, Turkey, 21 May 2021, vol.38, pp.45, (Full Text)

52. Correlation between serum thyroglobulin levels and involved neck compartment in persistent/recurrents node metastasis of papillary thyroid carcinoma

BAHÇECİOĞLU MUTLU A. B., ÖZKAN E., ARAZ M., ELHAN A. H.
19th İnternational Congress of Endocrinology, 2021, 24 February 2021, (Full Text)

53. Meme kanserinde evreleme amaçlı PEt/BT bulgularının tümör özellikleri ve prognoz ile ilişkisi

ARAZ M., SOYDAL Ç., BALTACIOĞLU M. H., KIR K. M.
32.Ulusal Nükleer Tıp Kongresi, Turkey, 20 - 21 November 2020, vol.6, pp.42-43, (Full Text) Sustainable Development

54. Diferansiye tiroid kanseri takibinde F-18-FDG PET/MR’xxnin PET/BT’xxye katkısı

ARAZ M., ÖZKAN E., BALTACIOĞLU M. H., KIR K. M., KÜÇÜK N. Ö., PEKER E., et al.
32.Ulusal Nükleer Tıp Kongresi, Turkey, 20 - 21 November 2020, vol.6, pp.30-31, (Full Text) Sustainable Development

55. Kolorektal kanser karaciğer metastazlarında transarteriyel radyoembolizasyon sonrası anjiogenik yatınıt prognostik önemi

SOYDAL Ç., NAK D., ARAZ M., Durmaz M., ÖZKAN E., ERGÜDER B. İ., et al.
32.Ulusal Nükleer Tıp Kongresi, Turkey, 20 - 21 November 2020, vol.6, pp.3, (Full Text) Sustainable Development

56. Nöroendokrin tümör karaciğer metastazları: tek fazlı rutin abdomen BT-BT histogram bulguları ile histolojik alt tipler tahmin edilebilir mi? Ga-68 DOTATATE PET/BT korelasyonu

GÜLPINAR B., PEKER E., SOYDAL Ç., ARAZ M., ELHAN A. H.
Uluslararası Katılımlı Radyoloji Kongresi TÜRKRAD 2019, 5 - 10 November 2019, (Summary Text)

57. Detectability of 18F-Choline PET/MR in primary hyperparathyroidism with negative neck ultrasound and Tc-99m MIBI scintigraphy

ARAZ M., NAK D., SOYDAL Ç., ERDEN M. İ., GÜLLÜ S., KÜÇÜK N. Ö.
Annual Congress of the EANM 2019, 12 - 16 October 2019, vol.46, (Summary Text)

58. Prognosis estimation with the ratio of largest tumor diameter to total tumar diameter in multifocal T1 differentiated thyroid cancer

ARAZ M., AKKUŞ P., SOYDAL Ç., ÖZKAN E., KIR K. M.
Annual Congress of the EANM 2019, 12 - 16 October 2019, vol.46, pp.952, (Summary Text) Sustainable Development

59. Analysis of prognostic factor in patients who received transarterial radioembolization for unresectable hepatocellular carcinoma

ARAZ M., NAK D., SOYDAL Ç., PEKER E., ERDEN M. İ., GÜLLÜ S., et al.
EANM 2019, 12 - 16 October 2019, vol.46, (Full Text)

60. Clinical outcome of low risk differentiated thyroid cancer patients treated with 30 mCi for ablation or without radioactive iodine therapy: a single center experience fron Turkey

ÖZKAN E., AKKUŞ P., BAHÇECİOĞLU MUTLU A. B., ARAZ M., SOYDAL Ç., GÜLLÜ S., et al.
SNM 2019 Annual Meeting, 22 - 25 June 2019, vol.60, (Summary Text) Sustainable Development

61. Clinical outcome of low risk differentiated thyroid cancer patients treatede with 30 mCi for ablation or 'thout radioactive iodine therapy : a single center experience from Turkey

ÖZKAN E., Akkus P., Bahcecioglu B., ARAZ M., SOYDAL Ç., GÜLLÜ S., et al.
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), California, United States Of America, 22 - 25 June 2019, vol.60, (Summary Text) Sustainable Development identifier

62. F-18-Choline PET/CT can be a useful tool to differentiate malignant-benign thyroid nodules.

ARAZ M., NAK D., SOYDAL Ç., GÜLLÜ S., KÜÇÜK N. Ö.
8th Balkan Congress of Nuclear Medicine, 10 - 14 April 2019, pp.16, (Full Text)

63. Detecetability of F-18-Choline PET/MR in primary hyperparathyroidism with nigative neck ultrasound and Tc-MIBI SPECT

ARAZ M., NAK D., SOYDAL Ç., PEKER E., ERDEN M. İ., GÜLLÜ S., et al.
8th Balkan Conrgess of Nuclcear Medicine, 10 - 14 April 2019, vol.1, (Full Text)

64. Comparison of bone scintigraphy and Ga-68-PSMA PET/CT in the detection of bone metastases of prostate carcinoma

ARAZ M., NAK D., SOYDAL Ç., PEKER E., ERDEN M. İ., GÜLLÜ S., et al.
8th Balkan Conrgess of Nuclcear Medicine, 10 - 14 April 2019, vol.1, (Summary Text)

65. Prognostic value of metabolikc parameters on baseline 18F FDG PET/CT in small cell lung cancer

ARAZ M., SOYDAL Ç., ÖZKAN E., ŞEN E., NAK D., KÜÇÜK N. Ö.
Annual Congress of the EANM 2018, 13 - 17 October 2018, (Summary Text) Sustainable Development

66. Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer

SOYDAL Ç., ARAZ M., ÜRÜN Y., Nak D., ÖZKAN E., KÜÇÜK N. Ö.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text) Sustainable Development identifier

67. The Efficacy of 18F Choline PET/CT in comparison to Tc99m MIBI SPECT/CT in the Localisation of Hyperfunctioning Parathyroid Gland in primary Hyperparathyroidism

ARAZ M., SOYDAL Ç., ÖZKAN E., KIR K. M., İBİŞ E., Gullu S., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text) identifier

68. The Related Factors with Brown Fat Activation in 18F-FDG PET/CT

SOYDAL Ç., ARAZ M., Gulpinar B., Akkus P., ÖZKAN E., Sahin M.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text) identifier

69. The role of Thyroglobulin doubling time in the follow up of differentiated thyroid cancer and its relationship with demographic and histopathologic risk factors and with 18F FDG PET/CT parameters

ARAZ M., SOYDAL Ç., ÖZKAN E., Akkus P., Nak D., KÜÇÜK N. Ö., et al.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45, (Summary Text) Sustainable Development identifier

70. Diferansiye tiroid kanseri hastalarının takibinde tiroglobulin doubling time’xxin yeri, bazal demografik ve histopatalojik risk faktörleri ve F-18 FDG PET/BT parametreleri ile ilişkisi

ÖZKAN E., SOYDAL Ç., NAK D., CİVRİZ BOZDAĞ S., ARAZ M., SENO C., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Summary Text) Sustainable Development

71. Primer hiperparatiroidi hastalarında hiperfonksiyone paratiroid bezinin lokalizasyonunda F-18 Kolin PET/BMT’nin rolü ve Tc-99m MIBI SPECT/BT ile karşılaştırılması

ARAZ M., SOYDAL Ç., ÖZKAN E., KIR K. M., İBİŞ E., GÜLLÜ S., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Full Text)

72. Erken evre hodgkin lenfomada progresyonsuz sağkalımı belirlemede FDG pET/BT parametrelerinin değeri

ÖZKAN E., SOYDAL Ç., NAK D., CİVRİZ BOZDAĞ S., ARAZ M., SENO C., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Summary Text)

73. Lu-177 PSMA tedavisi uygulanan kastrasyona dirençli metastatik prostat kanserli hastalarda serum PSC yanıtının prognostik önemi

ÖZKAN E., SOYDAL Ç., NAK D., CİVRİZ BOZDAĞ S., ARAZ M., SENO C., et al.
30.Ulusal Nükleer Tıp Kongresi, Turkey, 11 - 15 April 2018, (Summary Text) Sustainable Development

74. The Relationship Between Disease Severity and Quatitative Parameters Derived From Tc-99m MIBI SPECT Images in Primary Hyperparathyroidism

ARAZ M., ÇAYIR D., YALÇINDAĞ A., ÇAKAL E.
Annual Congress of the EANM 2016, Barcelona, Spain, 15 - 19 October 2016, vol.43, pp.574, (Summary Text)

75. The Relationship Between Disease Severity and Quantitative Parameters Derived From Tc-99m MIBI SPECT Images in Primary Hyperparathyroidism

Cayir D., ARAZ M., Yalcindag A., Cakal E.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, Spain, 15 - 19 October 2016, vol.43, (Summary Text) identifier

76. Factors Effecting The Sensitivity of Tc-99m MIBI Parathyroid SPECT

ARAZ M., ÇAYIR D., YALÇINDAĞ A., ÇAKAL E.
Annual Congress of the EANM 2016, Barcelona, Spain, 15 - 19 October 2016, vol.43, pp.573, (Summary Text)

77. Factors affecting the sensitivity of Tc-99m MIBI Parathyroid SPECT

ARAZ M., Cayir D., Erdogan M., Ucan B., Cakal E.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, Spain, 15 - 19 October 2016, vol.43, (Summary Text) identifier

78. Diferansiye Tiroid Karsinomu HastalarındaTc-99m MIBI ile Rezidü Tiroid Dokusu Değerlendirmesi: Olgu Sunumu

ÇAYIR D., ARAZ M., UÇAN B., ÇAKAL E.
38.Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Turkey, 11 - 15 May 2016, pp.195, (Summary Text)

79. Rekürren Hipertiroidi Olgusunda Ektopik Mediastinal Toksik Nodüler Tiroid Dokusu

ÇAYIR D., ARAZ M., UÇAN B., ÇAKAL E.
38.Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Turkey, 11 - 15 May 2016, pp.184-185, (Summary Text)

80. Dinamik Renal Sintigrafide Bifid Pelvis Görünümü ve Yo-Yo Reflü: İki Olgu Sunumu

ARAZ M., ÇAYIR D.
28.Ulusal Nükleer Tıp Kongresi, İzmir, Turkey, 6 - 10 April 2016, vol.2, pp.109-110, (Summary Text)

81. Paratiroid SPECT Çalışmasında İnsidental Hipofizer Tc-99m MIBI Tutulum ve Tutulum Yoğunluğunu Etkileyen Faktörler

ARAZ M., ÇAYIR D.
28.Ulusal Nükleer Tıp Kongresi, İzmir, Turkey, 6 - 10 April 2016, vol.2, pp.88, (Summary Text)

82. Tüm Vücut Kemik Sintigrafisinde Aktif Tiroid Nodülünde İnsidental Tc-99m MDP Tutulumu

ARAZ M., ÇAYIR D.
28.Ulusal Nükleer Tıp Kongresi, İzmir, Turkey, 6 - 10 April 2016, vol.2, pp.89, (Summary Text)

83. Primer Hiperparatiroidide Tc-99m MIBI SPECT Görüntülerinden Elde Edilen Kantitatif Parametreler ile Hastalık Ciddiyeti Arasındaki İlişki

ARAZ M., ÇAYIR D.
28.Ulusal Nükleer Tıp Kongresi, İzmir, Turkey, 6 - 10 April 2016, vol.2, pp.93, (Summary Text)

84. Tüm Vücut Kemik Sintigrafisinde Hot Kidneys Görünümü: İki Olgu Sunumu

ARAZ M., ÇAYIR D.
28.Ulusal Nükleer Tıp Kongresi, İzmir, Turkey, 6 - 10 April 2016, vol.2, pp.101-102, (Summary Text)

85. Dev Hidronefroz Olgusunda Teknesyum-99m (Tc-99m) Merkaptoasetil Triglisin (Mag-3) Diüretikli Böbrek Sintigrafisi Bulguları

ÇAYIR D., DEMİREL K., KORKMAZ M., KOCA G., ARAZ M.
27.Ulusal Nükleer Tıp Kongresi, Adana, Turkey, 1 - 05 April 2015, vol.1, pp.60, (Summary Text)

86. Üç Fazlı Kemik Sintigrafisinde Maligniteyi Taklit Eden Torakal Hemanjiom Bulguları

ÇAYIR D., DEMİREL K., KORKMAZ M., KOCA G., ARAZ M.
27.Ulusal Nükleer Tıp Kongresi, Adana, Turkey, 1 - 05 April 2015, vol.1, pp.56, (Summary Text)

87. Uçucu Madde Bağımlılığı Olan Ergenlerde Renal Hasar Gelişiminin Dinamik Böbrek Sintigrafisi ile Değerlendirilmesi

ÇAYIR D., DEMİREL K., KORKMAZ M., KOCA G., ARAZ M.
27.Ulusal Nükleer Tıp Kongresi, Adana, Turkey, 1 - 05 April 2015, vol.1, pp.60, (Summary Text)

88. Correlation of tumor marker levels with intensity of FDG uptake on PET imaging in epithelial cancers.

Mizrak D., ARAZ M., AKBULUT H., KÜÇÜK N. Ö., Alkan A., Yalcin S., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32, (Summary Text) Sustainable Development identifier

89. Torakal vertebra hemanjioumunun görüntüleme bulguları: nadir bir olgu sunumu.

ARAZ M., GÜLTEKİN S. S., DİLLİ A.
26.Ulusal Nükleer Tıp Kongresi, 16 - 20 April 2014, pp.41, (Summary Text)

90. Multipl endokrin neoplazi tip 2 olgusunda I-131 MIBG SPECT ile bilateral feokromasitomanın görüntüleme bulguları: Olgu Sunumu.

ARAZ M., GÜLTEKİN S. S., ÖZORMANCIK Z., DİLLİ A., SAYKI ARSLAN M.
26.Ulusal Nükleer Tıp Kongresi, 16 April 2014, pp.27, (Summary Text)

91. Over kanserli hastalarda serum CA125 düzeyi ile 18F-FDG-PET/BT pozitifliği arasındaki ilişkinin saptanması

Mızrak D., ARAZ M., AKBULUT H., Kubilay P., ALKAN A., KÜÇÜK N. Ö., et al.
5.Türk Tıbbi Onkoloji Kongresi, Turkey, 19 - 23 March 2014, (Summary Text) Sustainable Development

92. Meme kanserli hastalarda serum CEA ve CA 15-3 düzeyleri ile 18F-FDG PET/BT pozitifliği arasındaki ilişki

Mızrak D., ARAZ M., AKBULUT H., ÖZTÜRK B., ALKAN A., KÜÇÜK N. Ö., et al.
5.Türk Tıbbi Onkoloji Kongresi, Turkey, 19 - 23 March 2014, (Summary Text) Sustainable Development

93. Metastatik kolorektal kanserli hastalarda serum CEA düzeyleri ile 18F- FDG-PET/BT pozitifliği ilişkisi

Mızrak D., ARAZ M., ALKAN A., AKBULUT H., KÜÇÜK N. Ö., İÇLİ F.
5.Türk Tıbbi Onkoloji Kongresi, Turkey, 19 - 23 March 2014, (Summary Text) Sustainable Development

94. 18F-NaF PET/CT imaging in metastatic bone disease: Preliminary results from Turkey.

ARAZ M., ARAS G., KÜÇÜK N. Ö.
Annual Congress of the EANM 2012, 27 October 2012, vol.39, pp.474, (Summary Text)

95. Evaluatio of the response to SIRT in patients with HCC according to pretreatment MAA uptake.

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., ARAS G.
SNM 2012 Annual Meeting, 09 June 2012, vol.53, pp.227, (Summary Text)

96. 18F-NaF PET/CT imaging in metastatic bone disease: Preliminary results from Turkey.

ARAZ M., ARAS G., KÜÇÜK N. Ö.
SNM 2012 Annual Meeting, 09 June 2012, vol.53, pp.309, (Summary Text)

97. Prognostic importance of 18F-FDG uptake pattern of hepatocellular Cancer patients who received SIRT.

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., BİLGİÇ M. S., İBİŞ E.
SNM 2012 Annual Meeting, 09 June 2012, vol.53, pp.134, (Summary Text) Sustainable Development

98. CT and 18F-FDG PET/CT in staging or restaging of renal cell carcinoma.

ÖZKAN E., ARAZ M., SOYDAL Ç., FİLİK M., ARAS G.
SNM 2012 Annual Meeting, United States Of America, 09 June 2012, vol.53, pp.300-301, (Summary Text)

99. Evaluation of the response to SIRT in patients with HCC according to pretreatment MAA uptake.

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., ÖZKAN E., ARAS G.
1st Balkan Congress 2012, 04 April 2012, pp.27, (Summary Text)

100. Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT.

KÜÇÜK N. Ö., SOYDAL Ç., ARAZ M., BİLGİÇ M. S., İBİŞ E.
1st Balkan Congress 2012, 04 April 2012, pp.27, (Summary Text) Sustainable Development

101. 18F-NaF PET/CT imaging in metastatic bone disease: preliminary results

ARAZ M., ARAS G., KÜÇÜK N. Ö.
1st Balkan Congress, 2012, 04 April 2012, pp.16, (Summary Text)

102. The role of 18F-FDG-PET/CT in the preoperative staging and post-therapy up: Comparison with spiral CT.

ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.
IPET 2011, 08 November 2011, pp.86, (Summary Text)

103. The roleof 18F-FDG PET/CT in detecting colorectal cencer recurrence in patients with elevated CEA level.

ÖZKAN E., SOYDAL Ç., ARAZ M., İBİŞ E., KIR K. M., KÜÇÜK N. Ö., et al.
Annual Congress of the EANM 2011, 15 October 2011, vol.38, pp.241, (Summary Text)

104. The role of 18F-FDG positron emission tomography/computed tomography in detecting carcinoma of unknown primary.

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö., ARAS G.
Annual Congress of the EANM 2011, 15 October 2011, vol.38, pp.384, (Summary Text)

105. A retrospctive analysis of 18F-FDG PET/CT in the primary staging of non-small cell lung cencer (NSCLC).

ÖZKAN E., ARAZ M., SOYDAL Ç., ARAS G.
Annual Congress of the EANM 2011, 15 October 2011, vol.38, pp.125, (Summary Text)

106. Would the thyroglobulin threshold levels specific for evrey center lead to a significant change in the management of DTC patients?

KÜÇÜK N. Ö., SOYDAL Ç., FİLİK M., ARAZ M., ARAS G.
Annual Congress of the EANM 2011, 15 October 2011, vol.38, pp.347-348, (Summary Text)

107. Untra-arterial radioembolization with Y-90 for unresectable primary and metastatic level tumors and evaluation of treatment response by FDG PET/CT.

KÜÇÜK N. Ö., SOYDAL Ç., LAÇİN S., ÖZKAN E., ARAZ M., İBİŞ E.
Annual Congress of the EANM 2011, 15 October 2011, (Summary Text)

108. Thyroid papillary microcarcinoma and the role of radioiodine treatment

KÜÇÜK N. Ö., ARAZ M., SOYDAL Ç., ARAS G.
SNM 2011 Annual Meeting, 04 June 2011, vol.52, (Summary Text)

109. Impact of 18F-FDG positron emission tomography/computed tomography for detecting unknown primary tumor.

ÖZKAN E., SOYDAL Ç., ARAZ M., KÜÇÜK N. Ö., ARAS G.
SNM 2011 Annual Meeting, 4 - 08 June 2011, vol.52, (Summary Text)

110. Would the thyroglobulin threshold levels specific for every center lead to a significant change in the management of DTC patients?

KÜÇÜK N. Ö., SOYDAL Ç., FİLİK M., ARAZ M., ARAS G.
SNM 2011 Annual Meeting, 04 June 2011, vol.52, (Summary Text)

111. Myokard perfüzyon sintigrafisi sonuçlarının retrospektif analizi ve koroner anjiografi ili korelasyonu.

ARAZ M., SOYDAL Ç., SOBHANI S., ÖZKAN E., KÜÇÜK N. Ö., İBİŞ E., et al.
23.Ulusal Nükleer Tıp Kongresi, 27 April 2011, pp.100, (Summary Text)

112. Hiperparatiroidide paratiroid sintigrafisi: retrospektif analiz.

ÖZKAN E., BALİ ATAŞ E., ARAZ M., SOYDAL Ç., KIR K. M., ERBAY G.
23.Ulusal Nükleer Tıp Kongresi, 27 April 2011, pp.69, (Summary Text)

113. Diferansiye tiroid kanserli hastalarda hastalık progresyonunu ön görmede erken dönemde kabul edilecek eşik tiroglobulin değerinin önemi.

KÜÇÜK N. Ö., SOYDAL Ç., FİLİK M., ARAZ M., ARAS G.
23.Ulusal Nükleer Tıp Kongresi, 27 April 2011, pp.51, (Summary Text) Sustainable Development

114. Myokard perfüzyon sintigrafisinde adenozin sonuçlarımız.

ÖZKAN E., SOBHANI S., ARAZ M., KÜÇÜK N. Ö., KIR K. M., ERBAY G.
23.Ulusal Nükleer Tıp Kongresi, 27 April 2011, pp.101, (Summary Text)

115. The role of 18f-FDG-PET CT in malign melanome and comporison with conventional imaging modalities.

ÖZKAN E., ARAZ M., SOYDAL Ç., FİLİK M., KÜÇÜK N. Ö.
Annual Congress of the EANM 2010, 09 October 2010, vol.37, pp.442, (Summary Text)

116. The role of PET/CT in the evlauation of pancreatic cancer and suspected pancreas masses.

ÖZKAN E., SOYDAL Ç., ARAZ M., FİLİK M., YAĞCI Ş. G., KÜÇÜK N. Ö.
SNM 2010 Annual Meeting, 09 October 2010, vol.37, pp.432, (Summary Text) Sustainable Development

117. Is radioiodine treatment effective for childhood differentiated thyroid carcinomas: Results of five years follow up.

ÖZKAN E., SOYDAL Ç., ARAZ M., Lacin S., Yagci S. G., Filik M., et al.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text) identifier

118. The role of PET/CT in the evaluation of pancreatic cancer and suspected pancreas masses

ÖZKAN E., SOYDAL Ç., ARAZ M., Filik M., Yagci S. G., KÜÇÜK N. Ö.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 9 - 13 October 2010, vol.37, (Summary Text) Sustainable Development identifier

119. Differentiated thyroid carcinoma in childhood. Clinical experience up to five years follow up pariod after radioiodine treatment.

SOYDAL Ç., ARAZ M., LAÇİN S., YAĞCI Ş. G., KÜÇÜK N. Ö.
SNM 2010 Annual Meeting, 05 June 2010, vol.51, pp.329, (Summary Text)

120. The role of 18F-FDG-PET/CT in malign melanoma and comparison with conventional imaging modalities.

FİLİK M., ÖZKAN E., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.
9th International Nuclear Oncology Congress, 25 April 2010, vol.19, pp.95, (Summary Text)

121. The role of PET/CT in the evaluation of pancreatic cancer and suspected pancreatic masses.

ÖZKAN E., SOYDAL Ç., ARAZ M., FİLİK M., YAĞCI Ş. G., KÜÇÜK N. Ö.
9th International Nuclear Oncology Congress, 25 April 2010, vol.19, pp.93-94, (Summary Text) Sustainable Development

122. Clinical experience of PET/CT in soft tissue and osseos sarcomes.

ÖZKAN E., SOYDAL Ç., FİLİK M., ARAZ M., KÜÇÜK N. Ö.
9th International Nuclear Oncology Congress, 25 April 2010, vol.19, pp.93, (Summary Text)

123. İmmatür teratom takibindeve tedviye yanıtın değerlendirilmesinde 18F-FDG PET/CT: Olgu sunumu.

LAÇİN S., YAĞCI Ş. G., FİLİK M., ARAZ M., SOYDAL Ç., KÜÇÜK N. Ö.
Ulusal Nükleer Tıp Kongresi, 12 November 2009, (Summary Text)
Books 10

1. Nükleer Tıpta Tanı ve Tedavinin Geleceği

KÜÇÜK N. Ö., ARAZ M., ÖZTÜRK M.
in: Nükleer Tıp ve Moleküler Görüntüleme, Mustafa Kibar, Editor, Akademisyen Kitabevi, pp.1503-1509, 2023

2. Tiroid Sintigrafisi ve Radyoaktif İyot Uptake Ölçümü Kılavuzu

Araz M., Soydal Ç.
in: Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu, Tiroid Çalışma Grubu, Editor, BAYT Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Şti., Ankara, pp.43-50, 2023

3. Endokrinolojide Diğer Nükleer Görüntüleme ve Tedavi Yöntemleri

ARAZ M., ÖZKAN E.
in: Klinik Endokrinoloji, Bekir Uçan, Muhammed Kızılgül, Editor, Hipokrat Kitabevi, pp.685-697, 2022

4. Baş Boyun Kanserlerinde PET(in Yeri ve Önemi

ARAZ M., DEMİR B., ÖZKAN E.
in: Kulak Burun Boğaz Baş Boyun Cerrahisi, T.Metin Önerci, M.Hakan Korkmaz, Editor, Güneş Tıp Kitabevleri, pp.71-82, 2021

5. Graves Hastalığında Radyonüklid Tedavi

ARAZ M., ÖZKAN E.
in: Radyonüklit Tedavi, Prof.Dr.Recep Bekiş, Prof.Dr.BErna Polack, Prof.Dr.Murat Fani Bozkurt, Editor, O’xxTıp Kitapevi, pp.94-113, 2020

6. Parkinson Hastalığı Tanısında Nükleer Tıp Görüntüleme Yöntemleri

ARAZ M., KÜÇÜK N. Ö.
in: Hareket Bozuklukları ve Akıl Notları, Muhittin Cenk Akbostancı, Fatma Tuğra Karaarslan Türk, Editor, Güneş Tıp Yayınevi, pp.86-90, 2020

7. Medüller Tiroid Kanserinde Radyonüklid Görüntüleme ve Radyonüklid Tedaviler

ARAZ M., KÜÇÜK N. Ö.
in: Tiroid Kanseri Güncel Yaklaşım, Prof.Dr.Bekir Çakır, Editor, Akademisyen Kitapevi, pp.521-530, 2020 Sustainable Development

8. Karaciğer Tümörlerinde İntraarteriyel Mikroküre Tedavisi Sonuçları

Araz M., Küçük N. Ö.
in: Türkiye Klinikleri Özel Konular - Primer ve Metastatik Karaciğer Tümörlerinde Radyonüklid Tedavi, Prof.Dr.K.Metin KIR, Editor, Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş., Ankara, pp.26-31, 2018

9. Radioiodine therapy of malignant thyroid diseases

Çayır D., Araz M.
in: Radionuclide Treatments, Doç.Dr.Çiğdem SOYDAL, Editor, INTECH, Rijeka, pp.21-31, 2017

10. I-131 metaiodobenzylguanidine therapy of neuroectodermal tumors

Araz M., Çayır D.
in: Radionuclide Treatments, Doç.Dr.Çiğdem SOYDAL, Editor, INTECH, Rijeka, pp.35-49, 2017
Metrics

Publication

241

Publication (WoS)

84

Publication (Scopus)

79

Citation (WoS)

277

H-Index (WoS)

8

Citation (Scopus)

300

H-Index (Scopus)

9

Project

15

Thesis Advisory

1

Open Access

35
UN Sustainable Development Goals